Mauro AG - Search Results

1

Novel Pathophysiological, Diagnostic and Therapeutic Concepts in Acute and Recurrent Pericarditis.

Bonaventura A, Thomas GK, Golino M, Mauro AG, Vecchié A, Del Buono MG, Toldo S, Potere N, Abbate A. Bonaventura A, et al. Among authors: mauro ag. Rev Cardiovasc Med. 2023 Mar 3;24(3):77. doi: 10.31083/j.rcm2403077. eCollection 2023 Mar. Rev Cardiovasc Med. 2023. PMID: 39077487 Free PMC article. Review.

2

An update on the pathophysiology of acute and recurrent pericarditis.

Bonaventura A, Vecchié A, Mauro AG, Brucato AL, Imazio M, Abbate A. Bonaventura A, et al. Among authors: mauro ag. Panminerva Med. 2021 Sep;63(3):249-260. doi: 10.23736/S0031-0808.20.04205-6. Epub 2020 Dec 18. Panminerva Med. 2021. PMID: 33337127

3

Advances in pharmacotherapy for acute and recurrent pericarditis.

Vecchié A, Del Buono MG, Mauro AG, Cremer PC, Imazio M, Klein AL, Abbate A, Dentali F, Bonaventura A. Vecchié A, et al. Among authors: mauro ag. Expert Opin Pharmacother. 2022 Apr;23(6):681-691. doi: 10.1080/14656566.2022.2054327. Epub 2022 Mar 20. Expert Opin Pharmacother. 2022. PMID: 35311434 Review.

4

A Preclinical Translational Study of the Cardioprotective Effects of Plasma-Derived Alpha-1 Anti-trypsin in Acute Myocardial Infarction.

Mauro AG, Mezzaroma E, Marchetti C, Narayan P, Del Buono MG, Capuano M, Prestamburgo A, Catapano S, Salloum FN, Abbate A, Toldo S. Mauro AG, et al. J Cardiovasc Pharmacol. 2017 May;69(5):273-278. doi: 10.1097/FJC.0000000000000474. J Cardiovasc Pharmacol. 2017. PMID: 28195949

5

Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury.

Toldo S, Mauro AG, Cutter Z, Abbate A. Toldo S, et al. Among authors: mauro ag. Am J Physiol Heart Circ Physiol. 2018 Dec 1;315(6):H1553-H1568. doi: 10.1152/ajpheart.00158.2018. Epub 2018 Aug 31. Am J Physiol Heart Circ Physiol. 2018. PMID: 30168729 Free PMC article. Review.

6

An Orally Available NLRP3 Inflammasome Inhibitor Prevents Western Diet-Induced Cardiac Dysfunction in Mice.

Carbone S, Mauro AG, Prestamburgo A, Halquist MS, Narayan P, Potere N, Mezzaroma E, Van Tassell BW, Abbate A, Toldo S. Carbone S, et al. Among authors: mauro ag. J Cardiovasc Pharmacol. 2018 Dec;72(6):303-307. doi: 10.1097/FJC.0000000000000628. J Cardiovasc Pharmacol. 2018. PMID: 30422890 Free PMC article.

7

The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the Mouse.

Toldo S, Mauro AG, Cutter Z, Van Tassell BW, Mezzaroma E, Del Buono MG, Prestamburgo A, Potere N, Abbate A. Toldo S, et al. Among authors: mauro ag. J Cardiovasc Pharmacol. 2019 Apr;73(4):215-222. doi: 10.1097/FJC.0000000000000658. J Cardiovasc Pharmacol. 2019. PMID: 30747785

8

Low Density Lipoprotein Receptor-Related Protein-1 in Cardiac Inflammation and Infarct Healing.

Potere N, Del Buono MG, Mauro AG, Abbate A, Toldo S. Potere N, et al. Among authors: mauro ag. Front Cardiovasc Med. 2019 Apr 26;6:51. doi: 10.3389/fcvm.2019.00051. eCollection 2019. Front Cardiovasc Med. 2019. PMID: 31080804 Free PMC article. Review.

9

NLRP3 Inflammasome in Acute Myocardial Infarction.

Mauro AG, Bonaventura A, Mezzaroma E, Quader M, Toldo S. Mauro AG, et al. J Cardiovasc Pharmacol. 2019 Sep;74(3):175-187. doi: 10.1097/FJC.0000000000000717. J Cardiovasc Pharmacol. 2019. PMID: 31356555 Review.

10

Drugs to Inhibit the NLRP3 Inflammasome: Not Always On Target.

Mauro AG, Bonaventura A, Abbate A. Mauro AG, et al. J Cardiovasc Pharmacol. 2019 Sep;74(3):225-227. doi: 10.1097/FJC.0000000000000729. J Cardiovasc Pharmacol. 2019. PMID: 31415453 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters